Gena Pharmaceuticals Limited, a under liquidation public limited company, was established on 11 May 2004 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239WB2004PLC098504. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.87 Cr.
It upholds a active non-compliant status. Employing 32 professional, Its leadership includes Suresh Kumar Sharma (Additional Director), Arabind Kumar Mishra (Additional Director), Vijaykumar Kanoria (Director). Past directors included Raj Kamal Kanoria, Vijaykumar Kanoria, Govind Prasad Kanoria. It holds ₹32.29 Cr open charges and ₹11.54 Cr settled loans. Its latest AGM occurred on 28 December 2020, with the balance sheet filed on 31 March 2020. It is based at 7/2/1, Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, 700128.
U24239WB2004PLC098504
098504
11 May 2004
₹3.00 Cr
₹2.87 Cr
Roc Kolkata
Unlisted
Under Liquidation
Explore comprehensive insights into Gena Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Kumar Sharma | Additional Director | 16 Dec 2022 | Current |
| Arabind Kumar Mishra | Additional Director | 30 Sep 2011 | Current |
| Vijaykumar Kanoria | Director | 23 May 2012 | Current |
| Abhishek Kumar Shukla | Additional Director | 04 Jun 2019 | Current |
| Santosh Kumar Sharma | Additional Director | 16 Dec 2022 | Current |
| Rintu Bhattacharjee | Additional Director | 16 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 04 Jun 2019 | Past |
| Pramod Abcsdd | Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 17 May 2012 | Past |
| Pramod Abcsdd | Additional Director | 17 May 2012 | Past |
| Pramod Abcsdd | Additional Director | 06 Mar 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gena Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 29.58% decrease. The company also saw a substantial improvement in profitability, with a 22.3% increase in profit. The company's net worth dipped by a decrease of 1.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Gena Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹322,913,000.00
₹115,380,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2008 | Edelweiss Asset Reconstruction Company Limited | ₹12.66 Cr | Open |
| 28 Aug 2008 | Edelweiss Asset Reconstruction Company Limited | ₹12.66 Cr | Open |
| 03 Aug 2007 | Andhra Bank | ₹6.98 Cr | Open |
| 26 Oct 2004 | United Bank Of India | ₹11.54 Cr | Satisfied |
Explore comprehensive loan charge details -
Gena Pharmaceuticals has a workforce of 32 employees as of Jan 15, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gena Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gena Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Suresh Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 28 days . was completed.
Progress on Santosh Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 28 days . was documented.
Rintu Bhattacharjee was appointed as a Additional Director was appointed as a Additional Director on 16 Dec 2022 & has been associated with this company since 3 years 28 days . was recorded as a recent event.
Progress on Gena Pharmaceuticals Limited last Annual general meeting of members was held on 28 Dec 2020 as per latest MCA records. was documented.
The activity Gena Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kolkata. was completed.
Abhishek Kumar Shukla was appointed as a Additional Director was appointed as a Additional Director on 04 Jun 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.
The CIN of Gena Pharmaceuticals Limited is U24239WB2004PLC098504.
Gena Pharmaceuticals Limited is headquartered at 7/2/1, Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, 700128.
Gena Pharmaceuticals Limited was incorporated on 11 May 2004.
The current directors of Gena Pharmaceuticals Limited are
The primary industry of Gena Pharmaceuticals Limited is Manufacturing.
Gena Pharmaceuticals Limited is unlisted.
The authorized capital of Gena Pharmaceuticals Limited is ₹3.00 Cr, and the paid-up capital is ₹2.87 Cr.
The compliance status of Gena Pharmaceuticals Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX